EFFECTS OF THREE TREATMENT STRATEGIES ON ANEMIA AND QUALITY OF LIFE IN PATIENTS WITH SOLID TUMORS OR LYMPHOPROLIFERATIVE MALIGNANCIES: A RANDOMIZED 3-ARM STUDY ON ACTIVE (A) OR CONVENTIONAL (C) TRANSFUSIONS OR EPOETIN BETA (E). THE ACE STUDY.

Trial Profile

EFFECTS OF THREE TREATMENT STRATEGIES ON ANEMIA AND QUALITY OF LIFE IN PATIENTS WITH SOLID TUMORS OR LYMPHOPROLIFERATIVE MALIGNANCIES: A RANDOMIZED 3-ARM STUDY ON ACTIVE (A) OR CONVENTIONAL (C) TRANSFUSIONS OR EPOETIN BETA (E). THE ACE STUDY.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 29 Aug 2011

At a glance

  • Drugs Epoetin beta; Iron sucrose
  • Indications Chemotherapy-induced anaemia
  • Focus Therapeutic Use
  • Acronyms ACE
  • Sponsors Roche
  • Most Recent Events

    • 29 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top